Skip to main content

Table 2 Median, interquartile range (IQR), mean, standard deviation (SD) and p-values of outcome measurements at baseline

From: An evidence-based self-management package for urinary incontinence in older women: a mixed methods feasibility study

Variable

Dimensions

Intervention group

Control group

p-value

n

%

Median

IQR

Mean

SD

n

%

Median

IQR

Mean

SD

EQ-5D-5L

Mobility

            

0.675

No/slight problem

18

75.0%

    

20

80.0%

     

Moderate/Severe/extreme problem

6

25.0%

    

5

20.0%

     

Selfcare

            

0.527

No/slight problem

22

91.7%

    

24

96.0%

     

Moderate/Severe/extreme problem

2

8.3%

    

1

4.0%

     

Usual activities

            

0.662

No/slight problem

19

79.2%

    

21

84.0%

     

Moderate/Severe/extreme problem

5

20.8%

    

4

16.0%

     

Pain & discomfort

            

0.315

No/slight problem

14

58.3%

    

18

72.0%

     

Moderate/Severe/extreme problem

10

41.7%

    

7

28.0%

     

Anxiety & depression

            

0.524

No/slight problem

20

83.3%

    

19

76.0%

     

Moderate/Severe/extreme problem

4

16.7%

    

6

24.0%

     

Index

24

 

0.90

0.23

0.82

0.17

25

 

0.83

0.14

0.79

0.19

0.643

VAS

24

 

77.50

27.50

71.67

18.04

25

 

70.00

25.00

64.40

25.59

0.258

KHQ

Part I

             

General health perception (0-100)

24

 

25.00

25.00

33.33

21.70

25

 

25.00

25.00

32.00

15.34

0.804

Incontinence impact (0-100)

24

 

33.33

33.33

45.83

23.70

24

 

66.67

33.33

56.94

20.80

0.091

Part II

             

Role limitations (0-100)

24

 

16.67

33.33

20.14

22.51

25

 

33.33

33.33

33.33

24.06

0.054

Physical limitations (0-100)

24

 

16.67

41.67

22.92

22.42

25

 

33.33

33.33

30.67

20.79

0.216

Social limitations (0-100)

24

 

0.00

13.89

9.03

13.19

25

 

0.00

22.22

16.44

24.40

0.195

Personal relationships (0-100)

15

 

0.00

0.00

5.56

12.06

14

 

0.00

0.00

11.90

25.68

0.396

Emotions (0-100)

24

 

11.11

22.22

16.67

19.93

24

 

11.11

11.11

17.59

14.98

0.856

Sleep/energy (0-100)

24

 

33.33

41.67

37.50

28.34

25

 

50.00

50.00

47.33

32.16

0.263

Severity measures (0-100)

24

 

33.33

29.17

34.03

22.10

25

 

41.67

33.33

48.67

22.91

0.028

Part III

             

Symptom severity scale (0-30)

24

 

7.50

5.50

8.00

4.39

25

 

10.00

3.00

9.92

4.06

0.119

ICIQ-UI SF

Scale (0-21)

24

 

8.00

6.50

8.63

4.03

25

 

9.00

6.00

9.68

4.19

0.374

GSE-UI

Scale (0-120)

24

 

84.50

33.50

84.96

18.89

25

 

55.00

23.00

57.76

23.55

0.000

HADS

Anxiety scale (0-21)

24

 

6.50

6.50

7.13

5.12

25

 

7.00

5.00

7.56

4.56

0.755

Normal

13

54.2%

    

13

52.0%

    

0.868

Mild

7

29.2%

    

6

24.0%

     

Moderate

2

8.3%

    

4

16.0%

     

Severe

2

8.3%

    

2

8.0%

     

Depression scale (0-21)

24

 

3.00

3.50

3.67

3.29

25

 

3.00

4.00

3.88

4.02

0.840

Normal

20

83.3%

    

23

92.0%

    

0.318

Mild

2

8.3%

    

0

0.0%

     

Moderate

2

8.3%

    

1

4.0%

     

Severe

0

     

0

      
  1. T-tests for continuous variables and chi-square tests for categorical variablesVAS Visual Analogue Scale, KHQ King’s Health Questionnaire, ICIQ-UI SF International Consultation on Incontinence Questionnaire – urinary incontinence short form, GSE-UI Geriatric Self-Efficacy index for urinary incontinence, HADS Hospital Anxiety and Depression Scale
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us